Printer Friendly

Anaesthetic firm seeks operating partner.

SPECIALIST healthcare products company Maelor which is seeking a partner for the development and marketing of its intravenous general anaesthetic agent micelle propofol says it is in advanced negotiations with several major international pharmaceutical businesses.The Wrexham-based company is aiming to launch the patented drug delivery in about two years after further trials and will be aiming to capture a slice of a market worth hundreds of millions of pounds. Additional pre-clinical work has indicated that anaesthesia might be safely maintained for up to eight days using micelle propofol. A micelle can be used to dissolve materials such as propofol - the world's leading injectable general anaesthetic - which have little or no solubility in water.

Maelor chief executive Stephen Appelbee said: ``We are equally delighted with the pre-clinical work, which for the first time demonstrates the potential utility of micelle propofol in the maintenance of sedation. We can now offer to potential partners a formulation which can meet or exceed all the current therapeutic benchmarks.''
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business
Publication:Daily Post (Liverpool, England)
Date:Jan 7, 2003
Next Article:Thunderbirds are go - not to mention Sindy; MANAGEMENT BUY TOYMAKER IN pounds 62m DEAL.

Related Articles
Maelor's drug delivery system worth millions.
Healthcare firm calls in top consultants.
Maelor pinning hopes on two new products.
Slimmed-down Maelor progressing.
Company looking for a `sleeping partner' Talks over anaesthetic marketing.
Results a healthy sign for Maelor.
Maelor buys into new technology.
Healthcare firm heads for profit.
Heart attack victim was shocked he was part of 'training exercise' during triple bypass operation.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters